Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms (2024)
- Authors:
- USP affiliated authors: MERKEL, CHRISTIAN ALBERT - FM ; ULRICH, ALEXANDER HENNING - IQ ; GLASER, TALITA - IQ ; BENTO, CAROLINA ADRIANE - IQ
- Unidades: FM; IQ
- DOI: 10.3389/fphar.2023.1328398
- Subjects: ADENOSINA; CÉLULAS-TRONCO; CAFEÍNA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 14, p. 1-16 art. 1328398, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GLASER, Talita et al. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, v. 14, p. 1-16 art. 1328398, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2023.1328398. Acesso em: 10 fev. 2026. -
APA
Glaser, T., Martins, P., Beco, R., Bento, C. A., Cappellari, A. R., Oliveira, S. L. B. de, et al. (2024). Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, 14, 1-16 art. 1328398. doi:10.3389/fphar.2023.1328398 -
NLM
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2026 fev. 10 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398 -
Vancouver
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2026 fev. 10 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398 - P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior
- P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
- Adenosinergic-dopaminergic signaling in mood disorders: a mini-review
- Huntingtin protein maintains balanced energetics in mouse cardiomyocytes
- Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
- Purinergic signaling in brain physiology
- Purinergic signaling: an overview
- Purinergic receptors in neurogenic processes
- Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
- Purine nucleotides metabolism and signaling in huntington’s disease: search for a target for novel therapies
Informações sobre o DOI: 10.3389/fphar.2023.1328398 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3187537.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
